Chronic Migraine

RESEARCH STUDY CURRENTLY ENROLLING
call 757-591-8100

Chronic Migraine

Males and Females 18 years and older

The trial is being conducted to determine the safety and effectiveness of the medication zavegepant in the possible treatment of migraines.

Eligibility
  • At least 8 migraine days a month, and at least 15 headache days a month
  • Migraine attacks, on average, lasting about 4 – 72 hours if untreated
  • Must be able to distinguish migraine attacks from tension/cluster headaches
  • Must use 2 acceptable methods of contraception to avoid pregnancy throughout the study
Trial Duration

The trial will last up to 24 weeks involving 9 visits to our office

Compensation

You will be paid via check at the end of the trial.

Apply for this Study & take the first step towards better care for yourself today.

  • MM slash DD slash YYYY